Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Shibo Jiang and Shan Su.
Connection Strength

5.929
  1. Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants. Emerg Microbes Infect. 2021 Dec; 10(1):439-441.
    View in: PubMed
    Score: 0.982
  2. Double insult: flu bug enhances SARS-CoV-2 infectivity. Cell Res. 2021 05; 31(5):491-492.
    View in: PubMed
    Score: 0.943
  3. Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad-spectrum, and safe COVID-19 vaccines and therapeutics. Clin Transl Med. 2021 01; 11(1):e284.
    View in: PubMed
    Score: 0.922
  4. Learning from the past: development of safe and effective COVID-19 vaccines. Nat Rev Microbiol. 2021 03; 19(3):211-219.
    View in: PubMed
    Score: 0.908
  5. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2. Signal Transduct Target Ther. 2020 05 21; 5(1):71.
    View in: PubMed
    Score: 0.883
  6. Antivirals with common targets against highly pathogenic viruses. Cell. 2021 03 18; 184(6):1604-1620.
    View in: PubMed
    Score: 0.234
  7. Ring vaccination of COVID-19 vaccines in medium- and high-risk areas of countries with low incidence of SARS-CoV-2 infection. Clin Transl Med. 2021 02; 11(2):e331.
    View in: PubMed
    Score: 0.232
  8. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin. Signal Transduct Target Ther. 2020 06 12; 5(1):92.
    View in: PubMed
    Score: 0.222
  9. From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development. Microbes Infect. 2020 Jul - Aug; 22(6-7):245-253.
    View in: PubMed
    Score: 0.220
  10. Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors. J Virol. 2017 Jan 01; 91(1).
    View in: PubMed
    Score: 0.174
  11. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. Virus Res. 2014 Dec 19; 194:200-10.
    View in: PubMed
    Score: 0.150
  12. A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases. Acta Pharm Sin B. 2021 Aug 02.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.